ERIS stock news on Anadi Algo News

Monday, June 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
Stock Landing|19 matching stories

ERIS Share Price, Latest News & Sentiment

Latest AI-analyzed news for ERIS, along with saved share-price context, sentiment, quarterly filing summary, and related names in one page.

Stock Coverage Hub

ERIS News Today

Widely covered stock

The Indian IT sector is heavily reliant on global tech spending, particularly from the US and Europe. A potential global AI bubble burst could significantly impact demand for AI-related services.

Coverage
19
recent stories
Sources
4
distinct publishers
Bias Split
8 bullish / 8 bearish
1 neutral stories
Window
90d
recent coverage span
Saved Quote Snapshot

ERIS

Last Updated
23 May 2026
Price
NA
NA
52W Range
NA - NA
exchange snapshot
PE / VWAP
PE NA
VWAP NA
Trend Read
mixed
EMA stack mixed
Business Context
Industry: NA
Sector Trail: NA
Listing Date: NA
Market Structure
F&O Eligible: No
Indices: NA
Snapshot Source: mcp+nse
Quarterly Read

Quarter ended 31 Dec 2024

Consolidated results
What This Quarter Says

This is the first public financial report for ERIS. The company made Rs 727.45 crore in sales and a profit of Rs 86.93 crore. These numbers show how much money the company earned and kept, which helps you understand its business performance.

Revenue
Rs 727.45 cr
up 82.0% vs previous filing
Profit
Rs 86.93 cr
up 4783.7% vs previous filing
EPS / Finance Cost
EPS 6.15
Finance cost Rs 57.17 cr
Filing Context
Filed 5 Feb 2025, 5:32 pm
Figures are taken from the saved exchange filing, not from a live request.
Quick Reader Notes
  • Revenue this quarter: Rs 727.45 cr, up 82.0% vs previous filing.
  • Profit this quarter: Rs 86.93 cr, up 4783.7% vs previous filing.
  • EPS gives a quick sense of per-share earnings: 6.15.
How To Read This

Treat this block as a saved quarter snapshot. First see whether revenue and profit are improving, then read the latest news below to judge whether recent headlines support that trend or work against it.

ERIS FAQ

Why is ERIS in the news right now?

ERIS has appeared across 19 recent stories from 4 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.

Is ERIS coverage bullish or bearish right now?

ERIS coverage is currently mixed, with 8 bullish, 8 bearish, and 1 neutral analyzed stories in the recent window.

Which themes are moving with ERIS?

Recent ERIS coverage is clustering around Oil & Gas and Pharmaceuticals. Related names showing up alongside ERIS include IOC, NATCOPHARM, ONGC.

How should I use this ERIS news page?

Use this page as a coverage hub for ERIS: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.

Workflow View

Use ERIS coverage to build a cleaner watchlist.

A stock page is most useful when it helps you slow down, compare headlines, and separate one-off noise from a repeatable setup.

This is here if you want to go deeper, not as a push.Explore Anadi
Maintain a bearish bias on Indian IT stocks with high exposure to global AI projects; consider short-term hedges or reducing exposure.|Quick check: MARUTI bearish bias (+0.0% 1d), TATAMOTORS bullish bias (+0.0% 1d).
et_markets11 days ago

​Ipca Laboratories among 5 stocks showing bullish RSI upswing

The banking sector is currently experiencing a boost, contributing to overall market strength. For Indian Bank, this technical signal aligns with a positive sector backdrop, potentially amplifying its upward movement.

For Indian Bank, consider a long position with a bias towards continued upside, but maintain strict risk discipline given the inherent volatility in banking stocks.|Quick check: IPCALAB bullish bias (+2.9% 1d), ERIS bullish bias (+2.6% 1d).
et_markets20 days ago

Markets brace for a long conflict as investors reassess global equity risks: Andrew Freris

Geopolitical instability often drives capital towards defensive sectors. Pharma, with its relatively inelastic demand, tends to be a safe haven during such times, as evidenced by recent market trends.

Bearish-49.590%
5 facts
Maintain a bullish bias on select pharma stocks, focusing on companies with strong product pipelines and stable regulatory environments, while exercising strict risk management.|Quick check: SUNPHARMA neutral (+0.2% 1d), CIPLA bullish bias (+1.5% 1d).

Latest ERIS Stock Coverage

Positive bias for ERIS; look for continuation of momentum, with potential for short-term gains.|Quick check: ERIS bullish bias (+11.3% 1d), NIFTY neutral.
Maintain a bullish bias on Indian equities, particularly in domestic consumption and financial sectors, with a focus on quality stocks.|Quick check: NIFTY neutral, BANKNIFTY neutral.
Consider a neutral to slightly bullish bias for CASTROLIND, focusing on its defensive characteristics and dividend yield, given the stable but not explosive growth.|Quick check: CASTROLIND neutral (overbought), MARUTI bearish bias (-2.5% 1d).
Bias is positive for upstream oil & gas (ONGC) and negative for oil marketing companies (IOC, BPCL, HPCL) and high-fuel-cost sectors; maintain strict risk discipline.|Quick check: ONGC bullish bias (+0.1% 1d), IOC bullish bias (+2.0% 1d).
Adopt a defensive posture; consider short-term trades with strict stop-losses, favoring sectors with strong earnings visibility or defensive characteristics.|Quick check: VEDANTA neutral, HINDZINC bullish bias (-0.6% 1d).
Positive sentiment for hospitality stocks; look for potential upside in listed hotel and travel companies.|Quick check: TATASTEEL bullish bias (overbought), HINDALCO neutral (+0.1% 1d).
Given the prolonged geopolitical risks, traders should brace for continued crude oil price volatility; consider hedging strategies for oil-sensitive portfolios and look for opportunities in renewable energy stocks.
While the market has likely priced in these specific FY26 gains, traders should analyze the characteristics of these multi-bagger stocks to identify potential future outperformers in the current fiscal year.
The market has likely priced in these logistical adjustments; monitor freight costs and geopolitical developments for future impact on agricultural exporters.
Monitor sales volumes and market share reports for individual generic semaglutide players to gauge actual revenue impact amidst high competition.
Monitor NATCOPHARM and ERIS for potential upside as they enter the high-demand weight-loss drug market, but be mindful of competition and regulatory hurdles.
Given the poor IPO subscription and flat GMP, traders should exercise caution with upcoming IPOs, especially those with similar characteristics, and monitor broader market sentiment towards new listings.
Consider accumulating Reliance Industries (RELIANCE) on dips, as its outperformance in a weak market suggests strong defensive characteristics and potential for continued growth.
Given the 'higher for longer' rate outlook, traders should consider defensive plays and companies with strong balance sheets, while being cautious on highly leveraged or rate-sensitive sectors.
Avoid Rajputana Stainless post-listing due to weak subscription and GMP; exercise caution with other SME IPOs exhibiting similar characteristics.